Showing results (51-60 of 85) with videos related to
Sort By:
Pageof 9
International Journal of Molecular Sciences|March 10, 2022
Replication-Deficient Lymphocytic Choriomeningitis Virus-Vectored Vaccine Candidate for the Induction of T Cell Immunity against Mycobacterium tuberculosisElodie Belnoue, Alexis Vogelzang, Natalie E Nieuwenhuizen, et al.Molecular Therapy. Nucleic Acids|February 24, 2026
Non-cytolytic re-engineering of a viral vaccine vector enables durable effector-memory T cell immunity by reinforcing type I IFN inductionMatias Ciancaglini, Robin Avanthay, Anna-Friederike Marx, et al.Cell Host & Microbe|August 23, 2017
Interferon-γ-Driven iNOS: A Molecular Pathway to Terminal Shock in Arenavirus Hemorrhagic FeverMelissa M Remy, Mehmet Sahin, Lukas Flatz, et al.European Journal of Immunology|July 24, 2020
Fibroblast-derived IL-33 is dispensable for lymph node homeostasis but critical for CD8 T-cell responses to acute and chronic viral infectionPatricia Aparicio-Domingo, Hélène Cannelle, Matthew B Buechler, et al.The Journal of Experimental Medicine|October 15, 2014
Specific fibroblastic niches in secondary lymphoid organs orchestrate distinct Notch-regulated immune responsesNicolas Fasnacht, Hsin-Ying Huang, Ute Koch, et al.Frontiers in Oncology|November 1, 2021
Development and Characterization of a Novel Non-Lytic Cancer Immunotherapy Using a Recombinant Arenavirus Vector PlatformHenning Lauterbach, Sarah Schmidt, Kia Katchar, et al.Nature Communications|May 27, 2017
Replicating viral vector platform exploits alarmin signals for potent CD8+ T cell-mediated tumour immunotherapySandra M Kallert, Stephanie Darbre, Weldy V Bonilla, et al.Vaccine|November 23, 2024
Report of a SPEAC webinar 22 september 2023: Sensorineural hearing loss, lassa virus disease and vaccinesNicholas S Reed, Carmen C Brewer, Gideon Akintunde, et al.Science Immunology|November 23, 2016
Interferon-driven deletion of antiviral B cells at the onset of chronic infectionBenedict Fallet, Kerstin Narr, Yusuf I Ertuna, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|August 10, 2025
mRNA prime-boost vaccination promotes clonal continuity in germinal center reactions and broadens SARS-CoV-2 variant coverageMatias Ciancaglini, Jonas Fixemer, Cemre Seven, et al.Pageof 9